Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,198 | -34,036 | -27,147 | -19,718 | -15,477 |
| Depreciation Amortization | 1,004 | 598 | 263 | 129 | 459 |
| Accounts receivable | 777 | -262 | 712 | 698 | N/A |
| Accounts payable and accrued liabilities | 1,618 | 975 | 1,232 | 337 | N/A |
| Other Working Capital | 10,837 | 10,109 | 11,318 | 14,323 | 4,322 |
| Other Operating Activity | -685 | 1,403 | 588 | -268 | 1,029 |
| Operating Cash Flow | $-28,647 | $-21,213 | $-13,034 | $-4,499 | $-9,667 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -764 | -596 | -174 | -166 | -499 |
| Purchase Of Investment | -45,291 | -42,128 | N/A | N/A | N/A |
| Sale Of Investment | 2,510 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-43,545 | $-42,724 | $-174 | $-166 | $-499 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 680 | 699 | 394 | 89 | N/A |
| Common Stock Issued | 94,189 | 94,189 | 94,189 | 91,945 | N/A |
| Other Financing Activity | 56,291 | 56,433 | 56,522 | 56,626 | 18,325 |
| Financing Cash Flow | $151,160 | $151,321 | $151,105 | $148,660 | $18,325 |
| Exchange Rate Effect | -3,917 | -2,836 | -1,038 | -1,567 | -920 |
| Beginning Cash Position | 15,818 | 15,818 | 15,818 | 15,818 | 7,475 |
| End Cash Position | 90,869 | 100,366 | 152,677 | 158,246 | 14,714 |
| Net Cash Flow | $75,051 | $84,548 | $136,859 | $142,428 | $7,239 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,647 | -21,213 | -13,034 | -4,499 | -9,667 |
| Capital Expenditure | -764 | -596 | -174 | -166 | N/A |
| Free Cash Flow | -29,411 | -21,809 | -13,208 | -4,665 | -9,667 |